- Home
- PNR vs ICLR Comparison
PNR vs ICLR Comparison
Compare PNR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PNR | ICLR |
|---|---|---|
| Founded | 1966 | 1990 |
| Country | United Kingdom | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 15.1B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | PNR | ICLR |
|---|---|---|
| Price | $105.57 | $181.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $117.54 | ★ $202.31 |
| AVG Volume (30 Days) | ★ 1.7M | 952.8K |
| Earning Date | 02-03-2026 | 02-18-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 3.93 | ★ 7.47 |
| Revenue | $4,128,399,999.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $2.99 | N/A |
| Revenue Next Year | $4.38 | $0.29 |
| P/E Ratio | $26.81 | ★ $24.12 |
| Revenue Growth | ★ 0.83 | N/A |
| 52 Week Low | $74.25 | $125.10 |
| 52 Week High | $113.95 | $211.00 |
Technical Indicators
Market Signals| Indicator | PNR | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 45.87 |
| Support Level | $104.10 | $183.90 |
| Resistance Level | $108.54 | $191.00 |
| Average True Range (ATR) | 2.17 | 6.41 |
| MACD | 0.05 | -0.48 |
| Stochastic Oscillator | 52.35 | 44.33 |
Price Performance
Historical ComparisonAbout PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.1 billion in revenue in 2024.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.